Human menopausal gonadotropin and the risk of epithelial ovarian cancer

Fertility and Sterility

Volumn 65, Issue 1, 1996, Pages 13-18

  Shushan, A ^a   Paltiel, O ^a   Iscovich, J ^a   Elchalal, U ^a   Peretz, T ^a   Schenker, J G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

borderline ovarian tumors; gonadotropin; infertility; ovarian cancer; Ovulation induction

Indexed keywords

CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL;

EID: 0030028328     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58020-0     Document Type: Article

References (19)

1. S. Fishel P. Jackson Follicular stimulation for high tech pregnancies: are we playing it safe? Br Med J 299 1989 309 311
2. M. Atlas J. Mencjer Massive hyperstimulation and borderline malignancy carcinoma of the ovary: a possible association Acta Obstet Gynecol Scand 61 1982 261 263
3. G.L. Goldberg C.D. Runowicz Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation—Is there a link? Am J Obstet Gynecol 166 1992 853 854
4. A. Shushan A. Brzezinski J.G. Schenker Hormonal treatments and genital cancer: an update A.R. Genazzani F. Petraglia A.D. Genazzani Frontiers in gynecologic and obstetric investigation 1993 The Parthenon Publishing Group LTD New York 163 184
5. A.S. Whittemore R. Harris J. Itnyre the Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women Am J Epidemiol 136 1992 1184 1203
6. M.A. Rossing J.R. Daling N.S. Weiss D.E. Moore S.G. Self Ovarian tumors in a cohort of infertile women N Engl J Med 331 1994 771 776
7. R. Harris A.S. Whittemore J. Itnyre the Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women Am J Epidemiol 136 1992 1204 1211
8. P.L. Horn-Ross A.S. Whittemore J. Itnyre the Collaborative Ovarian Cancer Group Characteristics relating ovarian cancer risk: collaborative analysis of 12 US case-control studies. VI. Nonepithelial cancers among adults Epidemiology 3 1992 490 495
9. M.F. Fathalla Incessant ovulation—a factor in ovarian neoplasia? Lancet 2 1971 163
10. P. Hartge L.A. Brinton J.F. Rosenthal J.I. Cahill R.N. Hoover J. Waksberg Random digit dialing in selecting a population-based control group Am J Epidemiol 120 1984 825 833
11. J.J. Schlesselman Case-control studies. Design, conduct, analysis 1982 Oxford University Press New York
12. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development The reduction in risk of ovarian cancer associated with oral-contraceptive use N Engl J Med 316 1987 650 655
13. Central Bureau of Statistics Statistical abstract of Israel 45 1994 94 95
14. L. McGowan L. Parent W. Lednar H.J. Norris The woman at risk for developing ovarian cancer Gynecol Oncol 7 1979 325 344
15. International Federation of Fertility Societies (IFFS) Fertility drugs and ovarian cancer Fertil Steril 60 1993 406 408
16. D.E. Walters Ovarian cancer and pregnancy: comment on a paper by Whittemore et al Fertil Steril 61 1994 239 242
17. R. Spirtas S.C. Kaufman N.J. Alexander Fertility drugs and ovarian cancer: red alert or red herring? Fertil Steril 59 1993 291 293
18. J. Dietl Ovulation and ovarian cancer Lancet 338 1991 445
19. H.W. Nijman C.W. Burger J.P. Baak R. Schats J.B. Vermorken P. Kenemans Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases Eur J Cancer 28A 1992 1971 1973